参考文献/References:
[1] Mamone G,Di Piazza A,Carollo V,et al. Imaging of hepatic hemangioma: from A to Z[J]. Abdom Radiol(NY), 2020, 45:672- 691.
[2] Dasgupta R,Fishman SJ. ISSVA classification[J]. Semin Pediatr Surg, 2014, 23:158- 161.
[3] Mocchegiani F,Vincenzi P,Coletta M,et al. Prevalence and clinical outcome of hepatic haemangioma with specific reference to the risk of rupture: a large retrospective cross- sectional study[J]. Dig Liver Dis, 2016, 48:309- 314.
[4] 陈孝平,夏 锋,李雪松. 肝血管瘤诊断和治疗多学科专家共识(2019版)[J]. 临床肝胆病杂志, 2019, 35:1928- 1932.
[5] 贾科峰,于长路,孙 诚,等. 不同血供类型肝血管瘤的介入治疗效果长期随访评价[J]. 中华介入放射学电子杂志, 2018, 6:27- 31.
[6] 张学军,欧阳墉,马和平,等. 平阳霉素碘油栓塞术治疗肝海绵状血管瘤的远期疗效分析[J]. 中华放射学杂志, 2010, 44:298- 302.
[7] Dong W,Qiu B, Xu H,et al. Invasive management of symptomatic hepatic hemangioma[J]. Eur J Gastroenterol Hepatol,2019 ,31:1079- 1084.
[8] Zerpa R,Abdelghani EH,Iliescu G,et al. Enormous haemangioma of the liver[J]. BMJ Case Rep, 2019,12:e226983.
[9] 侯鹏高. 肝血管瘤分型与影像学诊断概述[J]. 齐齐哈尔医学院学报, 2014, 35:3045- 3046.
[10] 贾科峰,于长路,孙 诚,等. 不同血供特点肝血管瘤介入治疗的效果及并发症分析[J]. 中华肝胆外科杂志, 2018, 24:145- 149.
[11] Akhlaghpoor S,Torkian P,Golzarian J. Transarterial bleomycin- lipiodol embolization(B/LE) for symptomatic giant hepatic hema-ngioma[J]. Cardiovasc Intervent Radiol, 2018, 41:1674-1682.
[12] Hoekstra LT,Bieze M,Erdogan D, et al. Het reuzenhemangioom in de lever: diagnostiek en behandeling[Giant haemangioma of the liver: diagnosis and treatment][J]. Ned Tijdschr Geneeskd, 2012, 156:A3820.
[13] 宋晶晶,赵中伟,涂建飞,等. 射频消融联合肝动脉栓塞治疗巨大肝血管瘤的效果评价[J]. 中华介入放射学电子杂志, 2015, 3:201- 206.
[14] 虞晓龙,李建柯,黄优华,等. 经皮肝穿刺硬化与肝动脉栓塞治疗肝血管瘤的病例对照研究[J]. 分子影像学杂志, 2019, 42:155- 159.
[15] Jia K,Gao Z,Li M,et al. Interventional treatments for hepatic hemangioma: a state- of- the- art review[J]. J Interv Med, 2022,5: 6- 9.
[16] 陈 彤,姚建军,王维明,等. CT联合动脉造影对肝海绵状血管瘤诊断分型及介入栓塞治疗的意义[J]. 宁夏医学杂志, 2013, 35:1183- 1185.
[17] 贾科峰,于长路,孙 诚,等. 乏血供型肝血管瘤的介入治疗疗效分析及治疗模式探讨[J]. 中华消化杂志, 2018, 38:835- 840.
[18] 陈培培,陆 健,缪小芬,等. 钆塞酸二钠增强MRI假性廓清型肝血管瘤的征象分析[J]. 临床放射学杂志, 2019, 38:1335- 1339.
[19] 欧阳墉,张学军,欧阳雪晖,等.肝海绵状血管瘤的研究进展——图例式阐述[J]. 介入放射学杂志, 2012, 21:1- 6.
相似文献/References:
[1]蒋旭远,徐 克.平阳霉素碘油乳剂动脉栓塞治疗肝血管瘤的中远期疗效评价[J].介入放射学杂志,2012,(01):31.
JIANG Xu-yuan,XU Ke..The middle-long term effect of TAE with pingyangmycin-lipiodol emulsion for hepatic hemangioma[J].journal interventional radiology,2012,(04):31.
[2]尚国臣,刘 浩,刘 芳,等. 超声引导下经皮穿刺注射聚桂醇注射液治疗肝血管瘤[J].介入放射学杂志,2014,(06):522.
SHANG Guo- chen,LIU Hao,LIU Fang,et al. Ultrasound- guided percutaneous injection of lauromacrogol for the treatment of hepatic hemangiomas[J].journal interventional radiology,2014,(04):522.
[3]王 帅,曹喜华,张 峰.肝血管瘤微波消融术后血红蛋白尿相关因素分析 [J].介入放射学杂志,2020,29(06):596.
WANG Shuai,CAO Xihua,ZHANG Feng..Analysis of the related factors of hemoglobinuria in patients with hepatic hemangioma after microwave ablation[J].journal interventional radiology,2020,29(04):596.